Beijing Airdoc Technology Co., Ltd.
9
3
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
LED Low-Intensity Red Light for Myopia Control in Youth: Efficacy and Safety Study
Role: collaborator
Sustained Effect of Red-light Therapy for Myopia Control: A 2-Year Post-Trial Follow-up Study
Role: lead
Myopia Preventing With Distance-image Screen
Role: lead
Software Refraction With Mobilerone Versus Retinoscopy
Role: lead
Clinical Study of Light Therapy to Control Myopia Progression in Children
Role: lead
Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults
Role: lead
Slow Myopia Progression With Different Irradiance Light
Role: lead
Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old
Role: lead
Myopia Control Combined PBM With Myopic Defocus Lens in Children
Role: lead
All 9 trials loaded